Ex-Pfizer CEO Kindler Joins Health Care VC Firm Lux

Law360, New York (August 9, 2012, 12:38 PM EDT) -- Former Pfizer Inc. CEO and general counsel Jeff Kindler has signed on as a venture partner with New York venture capital firm Lux Capital, where he will help the firm identify new health care investment opportunities, Lux said Wednesday.

Kindler, who also serves as a senior advisor to global investment firm Paragon Pharmaceuticals LLC and on the boards of a handful of health care technology and drug companies, has extensive experience in the field and access to new and up-and-coming research and products of interest to...
To view the full article, register now.